Adjuvant pembrolizumab beneficial in renal cell carcinoma
Antibodies block specific viruses that cause arthritis, brain infections
19 August 2021A parent’s genes can influence a child’s educational success, inherited or not
19 August 2021Adjuvant pembrolizumab beneficial in renal cell carcinoma
(HealthDay)—For patients with clear-cell renal cell carcinoma at high risk for recurrence after nephrectomy, adjuvant therapy with pembrolizumab improves disease-free survival, according to a study published in the Aug. 19 issue of the New England Journal of Medicine.
